nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—DDR2—Endochondral Ossification—ALPL—Paget's disease of bone	0.0225	0.0714	CbGpPWpGaD
Regorafenib—Lymphopenia—Alendronate—Paget's disease of bone	0.0174	0.0269	CcSEcCtD
Regorafenib—Lymphopenia—Pamidronate—Paget's disease of bone	0.0133	0.0205	CcSEcCtD
Regorafenib—PDGFRA—Osteoblast Signaling—TNFRSF11B—Paget's disease of bone	0.0122	0.0388	CbGpPWpGaD
Regorafenib—Polyp—Risedronate—Paget's disease of bone	0.0118	0.0182	CcSEcCtD
Regorafenib—Hypophosphataemia—Pamidronate—Paget's disease of bone	0.0117	0.0181	CcSEcCtD
Regorafenib—Mucosal inflammation—Zoledronate—Paget's disease of bone	0.0112	0.0173	CcSEcCtD
Regorafenib—PDGFRB—Osteoblast Signaling—TNFRSF11B—Paget's disease of bone	0.011	0.035	CbGpPWpGaD
Regorafenib—PDGFRA—Osteoblast Signaling—BGLAP—Paget's disease of bone	0.0109	0.0348	CbGpPWpGaD
Regorafenib—RET—parathyroid gland—Paget's disease of bone	0.0109	0.296	CbGeAlD
Regorafenib—Hypomagnesaemia—Pamidronate—Paget's disease of bone	0.0107	0.0165	CcSEcCtD
Regorafenib—Cyst—Risedronate—Paget's disease of bone	0.0107	0.0165	CcSEcCtD
Regorafenib—Hypophosphataemia—Zoledronate—Paget's disease of bone	0.0107	0.0165	CcSEcCtD
Regorafenib—Hypothyroidism—Pamidronate—Paget's disease of bone	0.0106	0.0164	CcSEcCtD
Regorafenib—FGFR2—skull—Paget's disease of bone	0.0106	0.288	CbGeAlD
Regorafenib—Gastrooesophageal reflux disease—Alendronate—Paget's disease of bone	0.00988	0.0152	CcSEcCtD
Regorafenib—PDGFRB—Osteoblast Signaling—BGLAP—Paget's disease of bone	0.00986	0.0314	CbGpPWpGaD
Regorafenib—Hypomagnesaemia—Zoledronate—Paget's disease of bone	0.00979	0.0151	CcSEcCtD
Regorafenib—Hypocalcaemia—Alendronate—Paget's disease of bone	0.00975	0.015	CcSEcCtD
Regorafenib—Endocrine disorder—Risedronate—Paget's disease of bone	0.00864	0.0133	CcSEcCtD
Regorafenib—KDR—Signaling events mediated by TCPTP—CSF1—Paget's disease of bone	0.00815	0.0259	CbGpPWpGaD
Regorafenib—Gastrooesophageal reflux disease—Risedronate—Paget's disease of bone	0.00793	0.0122	CcSEcCtD
Regorafenib—Hypocalcaemia—Risedronate—Paget's disease of bone	0.00783	0.0121	CcSEcCtD
Regorafenib—Hypocalcaemia—Pamidronate—Paget's disease of bone	0.00744	0.0115	CcSEcCtD
Regorafenib—Proteinuria—Zoledronate—Paget's disease of bone	0.00708	0.0109	CcSEcCtD
Regorafenib—Protein urine present—Zoledronate—Paget's disease of bone	0.00698	0.0108	CcSEcCtD
Regorafenib—Musculoskeletal stiffness—Zoledronate—Paget's disease of bone	0.00693	0.0107	CcSEcCtD
Regorafenib—Gastrooesophageal reflux disease—Zoledronate—Paget's disease of bone	0.00689	0.0106	CcSEcCtD
Regorafenib—Hypocalcaemia—Zoledronate—Paget's disease of bone	0.00679	0.0105	CcSEcCtD
Regorafenib—UGT1A1—urine—Paget's disease of bone	0.00668	0.182	CbGeAlD
Regorafenib—Pain—Tiludronate—Paget's disease of bone	0.00668	0.0103	CcSEcCtD
Regorafenib—Neoplasm—Risedronate—Paget's disease of bone	0.00648	0.00998	CcSEcCtD
Regorafenib—Gastrointestinal pain—Tiludronate—Paget's disease of bone	0.00638	0.00984	CcSEcCtD
Regorafenib—Abdominal pain—Tiludronate—Paget's disease of bone	0.00617	0.00951	CcSEcCtD
Regorafenib—Dry skin—Alendronate—Paget's disease of bone	0.00594	0.00916	CcSEcCtD
Regorafenib—Gastroenteritis—Risedronate—Paget's disease of bone	0.00587	0.00904	CcSEcCtD
Regorafenib—Toxic epidermal necrolysis—Alendronate—Paget's disease of bone	0.00584	0.009	CcSEcCtD
Regorafenib—Stevens-Johnson syndrome—Etidronic acid—Paget's disease of bone	0.00581	0.00896	CcSEcCtD
Regorafenib—KDR—Integrins in angiogenesis—CSF1—Paget's disease of bone	0.00567	0.018	CbGpPWpGaD
Regorafenib—KDR—Notch-mediated HES/HEY network—BGLAP—Paget's disease of bone	0.00566	0.018	CbGpPWpGaD
Regorafenib—Neoplasm—Zoledronate—Paget's disease of bone	0.00562	0.00867	CcSEcCtD
Regorafenib—Asthenia—Tiludronate—Paget's disease of bone	0.0056	0.00863	CcSEcCtD
Regorafenib—KIT—Differentiation Pathway—CSF1—Paget's disease of bone	0.00546	0.0174	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling events mediated by TCPTP—CSF1—Paget's disease of bone	0.00539	0.0171	CbGpPWpGaD
Regorafenib—Diarrhoea—Tiludronate—Paget's disease of bone	0.00534	0.00823	CcSEcCtD
Regorafenib—TEK—Cell surface interactions at the vascular wall—INPP5D—Paget's disease of bone	0.00499	0.0159	CbGpPWpGaD
Regorafenib—Erythema multiforme—Etidronic acid—Paget's disease of bone	0.00498	0.00767	CcSEcCtD
Regorafenib—Stevens-Johnson syndrome—Alendronate—Paget's disease of bone	0.00495	0.00763	CcSEcCtD
Regorafenib—Headache—Tiludronate—Paget's disease of bone	0.00489	0.00754	CcSEcCtD
Regorafenib—Stomatitis—Alendronate—Paget's disease of bone	0.00487	0.0075	CcSEcCtD
Regorafenib—NTRK1—Circadian rythm related genes—TNFRSF11A—Paget's disease of bone	0.0048	0.0153	CbGpPWpGaD
Regorafenib—Alopecia—Etidronic acid—Paget's disease of bone	0.00465	0.00717	CcSEcCtD
Regorafenib—Nausea—Tiludronate—Paget's disease of bone	0.00464	0.00715	CcSEcCtD
Regorafenib—Haemoglobin—Alendronate—Paget's disease of bone	0.00451	0.00695	CcSEcCtD
Regorafenib—Hypokalaemia—Pamidronate—Paget's disease of bone	0.0045	0.00693	CcSEcCtD
Regorafenib—Haemorrhage—Alendronate—Paget's disease of bone	0.00448	0.00691	CcSEcCtD
Regorafenib—PDGFRB—Signaling events mediated by PTP1B—CSF1—Paget's disease of bone	0.00437	0.0139	CbGpPWpGaD
Regorafenib—Erythema multiforme—Alendronate—Paget's disease of bone	0.00424	0.00653	CcSEcCtD
Regorafenib—Anaemia—Etidronic acid—Paget's disease of bone	0.00423	0.00653	CcSEcCtD
Regorafenib—NTRK1—Neurotrophic factor-mediated Trk receptor signaling—SQSTM1—Paget's disease of bone	0.00418	0.0133	CbGpPWpGaD
Regorafenib—MAPK11—IL-4 Signaling Pathway—INPP5D—Paget's disease of bone	0.00418	0.0133	CbGpPWpGaD
Regorafenib—Hypokalaemia—Zoledronate—Paget's disease of bone	0.00411	0.00633	CcSEcCtD
Regorafenib—Leukopenia—Etidronic acid—Paget's disease of bone	0.0041	0.00632	CcSEcCtD
Regorafenib—Infestation NOS—Risedronate—Paget's disease of bone	0.00401	0.00618	CcSEcCtD
Regorafenib—Infestation—Risedronate—Paget's disease of bone	0.00401	0.00618	CcSEcCtD
Regorafenib—FGFR2—FGF signaling pathway—BGLAP—Paget's disease of bone	0.004	0.0127	CbGpPWpGaD
Regorafenib—Neutropenia—Pamidronate—Paget's disease of bone	0.004	0.00616	CcSEcCtD
Regorafenib—Alopecia—Alendronate—Paget's disease of bone	0.00396	0.00611	CcSEcCtD
Regorafenib—NTRK1—p73 transcription factor network—PML—Paget's disease of bone	0.00393	0.0125	CbGpPWpGaD
Regorafenib—RAF1—GMCSF-mediated signaling events—INPP5D—Paget's disease of bone	0.00387	0.0123	CbGpPWpGaD
Regorafenib—Infestation—Pamidronate—Paget's disease of bone	0.00381	0.00587	CcSEcCtD
Regorafenib—Infestation NOS—Pamidronate—Paget's disease of bone	0.00381	0.00587	CcSEcCtD
Regorafenib—Hepatobiliary disease—Risedronate—Paget's disease of bone	0.00379	0.00584	CcSEcCtD
Regorafenib—NTRK1—p75(NTR)-mediated signaling—SQSTM1—Paget's disease of bone	0.00379	0.012	CbGpPWpGaD
Regorafenib—FGFR1—FGF signaling pathway—BGLAP—Paget's disease of bone	0.00373	0.0118	CbGpPWpGaD
Regorafenib—Infection—Etidronic acid—Paget's disease of bone	0.00371	0.00572	CcSEcCtD
Regorafenib—Stomatitis—Pamidronate—Paget's disease of bone	0.00371	0.00572	CcSEcCtD
Regorafenib—MAPK11—Regulation of retinoblastoma protein—BGLAP—Paget's disease of bone	0.00371	0.0118	CbGpPWpGaD
Regorafenib—RAF1—Endothelin Pathways—CALCA—Paget's disease of bone	0.0037	0.0117	CbGpPWpGaD
Regorafenib—BRAF—mTOR signaling pathway—PML—Paget's disease of bone	0.00365	0.0116	CbGpPWpGaD
Regorafenib—Neutropenia—Zoledronate—Paget's disease of bone	0.00365	0.00563	CcSEcCtD
Regorafenib—CYP2C19—urine—Paget's disease of bone	0.00362	0.0987	CbGeAlD
Regorafenib—Haemoglobin—Risedronate—Paget's disease of bone	0.00362	0.00557	CcSEcCtD
Regorafenib—Anaemia—Alendronate—Paget's disease of bone	0.00361	0.00556	CcSEcCtD
Regorafenib—Haemorrhage—Risedronate—Paget's disease of bone	0.0036	0.00555	CcSEcCtD
Regorafenib—Urinary tract disorder—Risedronate—Paget's disease of bone	0.00355	0.00548	CcSEcCtD
Regorafenib—Connective tissue disorder—Risedronate—Paget's disease of bone	0.00354	0.00545	CcSEcCtD
Regorafenib—Weight decreased—Zoledronate—Paget's disease of bone	0.00353	0.00544	CcSEcCtD
Regorafenib—Urethral disorder—Risedronate—Paget's disease of bone	0.00353	0.00544	CcSEcCtD
Regorafenib—RAF1—Interleukin-11 Signaling Pathway—BGLAP—Paget's disease of bone	0.00352	0.0112	CbGpPWpGaD
Regorafenib—FGFR1—Endochondral Ossification—ALPL—Paget's disease of bone	0.00351	0.0112	CbGpPWpGaD
Regorafenib—KIT—Kit receptor signaling pathway—INPP5D—Paget's disease of bone	0.00351	0.0112	CbGpPWpGaD
Regorafenib—Infestation NOS—Zoledronate—Paget's disease of bone	0.00348	0.00536	CcSEcCtD
Regorafenib—Infestation—Zoledronate—Paget's disease of bone	0.00348	0.00536	CcSEcCtD
Regorafenib—Haemoglobin—Pamidronate—Paget's disease of bone	0.00344	0.0053	CcSEcCtD
Regorafenib—Haemorrhage—Pamidronate—Paget's disease of bone	0.00342	0.00527	CcSEcCtD
Regorafenib—Stomatitis—Zoledronate—Paget's disease of bone	0.00339	0.00523	CcSEcCtD
Regorafenib—Urinary tract disorder—Pamidronate—Paget's disease of bone	0.00338	0.00521	CcSEcCtD
Regorafenib—Connective tissue disorder—Pamidronate—Paget's disease of bone	0.00336	0.00518	CcSEcCtD
Regorafenib—Urethral disorder—Pamidronate—Paget's disease of bone	0.00335	0.00517	CcSEcCtD
Regorafenib—Cardiac disorder—Risedronate—Paget's disease of bone	0.00334	0.00515	CcSEcCtD
Regorafenib—EPHA2—Direct p53 effectors—PML—Paget's disease of bone	0.00333	0.0106	CbGpPWpGaD
Regorafenib—Angiopathy—Risedronate—Paget's disease of bone	0.00326	0.00503	CcSEcCtD
Regorafenib—ABL1—Validated transcriptional targets of TAp63 isoforms—PML—Paget's disease of bone	0.00324	0.0103	CbGpPWpGaD
Regorafenib—Mediastinal disorder—Risedronate—Paget's disease of bone	0.00324	0.005	CcSEcCtD
Regorafenib—RAF1—Interleukin-2 signaling—INPP5D—Paget's disease of bone	0.0032	0.0102	CbGpPWpGaD
Regorafenib—MAPK11—p73 transcription factor network—PML—Paget's disease of bone	0.00319	0.0101	CbGpPWpGaD
Regorafenib—Cardiac disorder—Pamidronate—Paget's disease of bone	0.00317	0.00489	CcSEcCtD
Regorafenib—Infection—Alendronate—Paget's disease of bone	0.00316	0.00488	CcSEcCtD
Regorafenib—Malnutrition—Risedronate—Paget's disease of bone	0.00313	0.00483	CcSEcCtD
Regorafenib—MAPK11—Glucocorticoid receptor regulatory network—BGLAP—Paget's disease of bone	0.00312	0.00991	CbGpPWpGaD
Regorafenib—Angiopathy—Pamidronate—Paget's disease of bone	0.0031	0.00478	CcSEcCtD
Regorafenib—RAF1—IL-3 Signaling Pathway—INPP5D—Paget's disease of bone	0.00309	0.00983	CbGpPWpGaD
Regorafenib—Urinary tract disorder—Zoledronate—Paget's disease of bone	0.00308	0.00476	CcSEcCtD
Regorafenib—Mediastinal disorder—Pamidronate—Paget's disease of bone	0.00308	0.00475	CcSEcCtD
Regorafenib—Connective tissue disorder—Zoledronate—Paget's disease of bone	0.00307	0.00473	CcSEcCtD
Regorafenib—Urethral disorder—Zoledronate—Paget's disease of bone	0.00306	0.00472	CcSEcCtD
Regorafenib—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.00306	0.00471	CcSEcCtD
Regorafenib—Alopecia—Pamidronate—Paget's disease of bone	0.00302	0.00466	CcSEcCtD
Regorafenib—Malnutrition—Pamidronate—Paget's disease of bone	0.00298	0.00459	CcSEcCtD
Regorafenib—Abdominal pain—Etidronic acid—Paget's disease of bone	0.00296	0.00456	CcSEcCtD
Regorafenib—Cardiac disorder—Zoledronate—Paget's disease of bone	0.0029	0.00447	CcSEcCtD
Regorafenib—Anaemia—Risedronate—Paget's disease of bone	0.00289	0.00446	CcSEcCtD
Regorafenib—ABL1—Apoptosis-related network due to altered Notch3 in ovarian cancer—SQSTM1—Paget's disease of bone	0.00285	0.00905	CbGpPWpGaD
Regorafenib—Angiopathy—Zoledronate—Paget's disease of bone	0.00283	0.00437	CcSEcCtD
Regorafenib—Mediastinal disorder—Zoledronate—Paget's disease of bone	0.00282	0.00434	CcSEcCtD
Regorafenib—CYP2C9—urine—Paget's disease of bone	0.00281	0.0766	CbGeAlD
Regorafenib—EPHA2—NRF2 pathway—SQSTM1—Paget's disease of bone	0.00279	0.00886	CbGpPWpGaD
Regorafenib—ABL1—Regulation of retinoblastoma protein—BGLAP—Paget's disease of bone	0.00278	0.00884	CbGpPWpGaD
Regorafenib—Alopecia—Zoledronate—Paget's disease of bone	0.00276	0.00426	CcSEcCtD
Regorafenib—Anaemia—Pamidronate—Paget's disease of bone	0.00275	0.00424	CcSEcCtD
Regorafenib—RAF1—AGE/RAGE pathway—ALPL—Paget's disease of bone	0.00275	0.00873	CbGpPWpGaD
Regorafenib—Pain—Alendronate—Paget's disease of bone	0.00272	0.0042	CcSEcCtD
Regorafenib—Malnutrition—Zoledronate—Paget's disease of bone	0.00272	0.00419	CcSEcCtD
Regorafenib—Hypertension—Risedronate—Paget's disease of bone	0.0027	0.00417	CcSEcCtD
Regorafenib—ABL1—DNA Damage Response—PML—Paget's disease of bone	0.0027	0.00858	CbGpPWpGaD
Regorafenib—RAF1—Kit receptor signaling pathway—INPP5D—Paget's disease of bone	0.00267	0.00848	CbGpPWpGaD
Regorafenib—Leukopenia—Pamidronate—Paget's disease of bone	0.00266	0.00411	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.00265	0.00408	CcSEcCtD
Regorafenib—NTRK1—BDNF signaling pathway—ALPL—Paget's disease of bone	0.00264	0.0084	CbGpPWpGaD
Regorafenib—Dry mouth—Risedronate—Paget's disease of bone	0.00261	0.00402	CcSEcCtD
Regorafenib—ABL1—miRNA Regulation of DNA Damage Response—PML—Paget's disease of bone	0.00261	0.00828	CbGpPWpGaD
Regorafenib—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.0026	0.00402	CcSEcCtD
Regorafenib—RAF1—Fc-epsilon receptor I signaling in mast cells—INPP5D—Paget's disease of bone	0.0026	0.00825	CbGpPWpGaD
Regorafenib—BRAF—B Cell Receptor Signaling Pathway—INPP5D—Paget's disease of bone	0.00259	0.00823	CbGpPWpGaD
Regorafenib—Hypertension—Pamidronate—Paget's disease of bone	0.00257	0.00396	CcSEcCtD
Regorafenib—Diarrhoea—Etidronic acid—Paget's disease of bone	0.00256	0.00394	CcSEcCtD
Regorafenib—Tremor—Zoledronate—Paget's disease of bone	0.00255	0.00393	CcSEcCtD
Regorafenib—ABL1—Neurotrophic factor-mediated Trk receptor signaling—SQSTM1—Paget's disease of bone	0.00255	0.00809	CbGpPWpGaD
Regorafenib—RAF1—Regulation of retinoblastoma protein—BGLAP—Paget's disease of bone	0.00254	0.00808	CbGpPWpGaD
Regorafenib—Infection—Risedronate—Paget's disease of bone	0.00254	0.00391	CcSEcCtD
Regorafenib—RAF1—mTOR signaling pathway—PML—Paget's disease of bone	0.00253	0.00803	CbGpPWpGaD
Regorafenib—Abdominal pain—Alendronate—Paget's disease of bone	0.00252	0.00388	CcSEcCtD
Regorafenib—Body temperature increased—Alendronate—Paget's disease of bone	0.00252	0.00388	CcSEcCtD
Regorafenib—Anaemia—Zoledronate—Paget's disease of bone	0.00251	0.00387	CcSEcCtD
Regorafenib—Nervous system disorder—Risedronate—Paget's disease of bone	0.00251	0.00386	CcSEcCtD
Regorafenib—Skin disorder—Risedronate—Paget's disease of bone	0.00248	0.00383	CcSEcCtD
Regorafenib—Leukopenia—Zoledronate—Paget's disease of bone	0.00243	0.00375	CcSEcCtD
Regorafenib—Infection—Pamidronate—Paget's disease of bone	0.00241	0.00372	CcSEcCtD
Regorafenib—RAF1—BCR signaling pathway—INPP5D—Paget's disease of bone	0.00241	0.00766	CbGpPWpGaD
Regorafenib—ABL1—p73 transcription factor network—PML—Paget's disease of bone	0.00239	0.00761	CbGpPWpGaD
Regorafenib—Nervous system disorder—Pamidronate—Paget's disease of bone	0.00238	0.00367	CcSEcCtD
Regorafenib—Thrombocytopenia—Pamidronate—Paget's disease of bone	0.00238	0.00367	CcSEcCtD
Regorafenib—Vomiting—Etidronic acid—Paget's disease of bone	0.00238	0.00366	CcSEcCtD
Regorafenib—Rash—Etidronic acid—Paget's disease of bone	0.00236	0.00363	CcSEcCtD
Regorafenib—Dermatitis—Etidronic acid—Paget's disease of bone	0.00235	0.00363	CcSEcCtD
Regorafenib—Hypertension—Zoledronate—Paget's disease of bone	0.00235	0.00362	CcSEcCtD
Regorafenib—Headache—Etidronic acid—Paget's disease of bone	0.00234	0.00361	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.0023	0.00354	CcSEcCtD
Regorafenib—Asthenia—Alendronate—Paget's disease of bone	0.00229	0.00352	CcSEcCtD
Regorafenib—Dry mouth—Zoledronate—Paget's disease of bone	0.00226	0.00349	CcSEcCtD
Regorafenib—Nausea—Etidronic acid—Paget's disease of bone	0.00222	0.00342	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.00221	0.0034	CcSEcCtD
Regorafenib—Infection—Zoledronate—Paget's disease of bone	0.0022	0.0034	CcSEcCtD
Regorafenib—Fatigue—Risedronate—Paget's disease of bone	0.0022	0.0034	CcSEcCtD
Regorafenib—Pain—Risedronate—Paget's disease of bone	0.00219	0.00337	CcSEcCtD
Regorafenib—Diarrhoea—Alendronate—Paget's disease of bone	0.00218	0.00336	CcSEcCtD
Regorafenib—BRAF—Senescence and Autophagy in Cancer—SQSTM1—Paget's disease of bone	0.00218	0.00693	CbGpPWpGaD
Regorafenib—Nervous system disorder—Zoledronate—Paget's disease of bone	0.00218	0.00335	CcSEcCtD
Regorafenib—Thrombocytopenia—Zoledronate—Paget's disease of bone	0.00217	0.00335	CcSEcCtD
Regorafenib—Skin disorder—Zoledronate—Paget's disease of bone	0.00216	0.00332	CcSEcCtD
Regorafenib—CYP3A4—urine—Paget's disease of bone	0.00214	0.0584	CbGeAlD
Regorafenib—Decreased appetite—Pamidronate—Paget's disease of bone	0.00211	0.00326	CcSEcCtD
Regorafenib—FGFR2—Ectoderm Differentiation—TNFRSF11B—Paget's disease of bone	0.00211	0.00669	CbGpPWpGaD
Regorafenib—NTRK1—BDNF signaling pathway—SQSTM1—Paget's disease of bone	0.0021	0.00668	CbGpPWpGaD
Regorafenib—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.0021	0.00323	CcSEcCtD
Regorafenib—Fatigue—Pamidronate—Paget's disease of bone	0.00209	0.00323	CcSEcCtD
Regorafenib—RAF1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—INPP5D—Paget's disease of bone	0.00209	0.00664	CbGpPWpGaD
Regorafenib—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.00209	0.00322	CcSEcCtD
Regorafenib—Pain—Pamidronate—Paget's disease of bone	0.00208	0.0032	CcSEcCtD
Regorafenib—Vomiting—Alendronate—Paget's disease of bone	0.00203	0.00312	CcSEcCtD
Regorafenib—Body temperature increased—Risedronate—Paget's disease of bone	0.00202	0.00311	CcSEcCtD
Regorafenib—Abdominal pain—Risedronate—Paget's disease of bone	0.00202	0.00311	CcSEcCtD
Regorafenib—Rash—Alendronate—Paget's disease of bone	0.00201	0.0031	CcSEcCtD
Regorafenib—Dermatitis—Alendronate—Paget's disease of bone	0.00201	0.00309	CcSEcCtD
Regorafenib—Headache—Alendronate—Paget's disease of bone	0.002	0.00308	CcSEcCtD
Regorafenib—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.00199	0.00306	CcSEcCtD
Regorafenib—NTRK1—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.00194	0.00616	CbGpPWpGaD
Regorafenib—Decreased appetite—Zoledronate—Paget's disease of bone	0.00193	0.00297	CcSEcCtD
Regorafenib—Abdominal pain—Pamidronate—Paget's disease of bone	0.00192	0.00296	CcSEcCtD
Regorafenib—Body temperature increased—Pamidronate—Paget's disease of bone	0.00192	0.00296	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.00192	0.00295	CcSEcCtD
Regorafenib—Fatigue—Zoledronate—Paget's disease of bone	0.00191	0.00295	CcSEcCtD
Regorafenib—Pain—Zoledronate—Paget's disease of bone	0.0019	0.00293	CcSEcCtD
Regorafenib—Nausea—Alendronate—Paget's disease of bone	0.00189	0.00292	CcSEcCtD
Regorafenib—BRAF—Integrated Breast Cancer Pathway—PML—Paget's disease of bone	0.00188	0.00599	CbGpPWpGaD
Regorafenib—NTRK1—Circadian rythm related genes—PML—Paget's disease of bone	0.00186	0.00592	CbGpPWpGaD
Regorafenib—Asthenia—Risedronate—Paget's disease of bone	0.00183	0.00283	CcSEcCtD
Regorafenib—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.00181	0.0028	CcSEcCtD
Regorafenib—MAPK11—Cellular responses to stress—VCP—Paget's disease of bone	0.0018	0.00572	CbGpPWpGaD
Regorafenib—RAF1—B Cell Receptor Signaling Pathway—INPP5D—Paget's disease of bone	0.00179	0.0057	CbGpPWpGaD
Regorafenib—MAPK11—Regulation of toll-like receptor signaling pathway—SQSTM1—Paget's disease of bone	0.00176	0.00559	CbGpPWpGaD
Regorafenib—Abdominal pain—Zoledronate—Paget's disease of bone	0.00175	0.0027	CcSEcCtD
Regorafenib—Body temperature increased—Zoledronate—Paget's disease of bone	0.00175	0.0027	CcSEcCtD
Regorafenib—Diarrhoea—Risedronate—Paget's disease of bone	0.00175	0.0027	CcSEcCtD
Regorafenib—Asthenia—Pamidronate—Paget's disease of bone	0.00174	0.00269	CcSEcCtD
Regorafenib—BRAF—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.00172	0.00546	CbGpPWpGaD
Regorafenib—Diarrhoea—Pamidronate—Paget's disease of bone	0.00166	0.00256	CcSEcCtD
Regorafenib—RAF1—Signaling by Interleukins—INPP5D—Paget's disease of bone	0.00164	0.00523	CbGpPWpGaD
Regorafenib—Vomiting—Risedronate—Paget's disease of bone	0.00163	0.0025	CcSEcCtD
Regorafenib—Rash—Risedronate—Paget's disease of bone	0.00161	0.00248	CcSEcCtD
Regorafenib—Dermatitis—Risedronate—Paget's disease of bone	0.00161	0.00248	CcSEcCtD
Regorafenib—Headache—Risedronate—Paget's disease of bone	0.0016	0.00247	CcSEcCtD
Regorafenib—Asthenia—Zoledronate—Paget's disease of bone	0.00159	0.00245	CcSEcCtD
Regorafenib—Vomiting—Pamidronate—Paget's disease of bone	0.00154	0.00238	CcSEcCtD
Regorafenib—Rash—Pamidronate—Paget's disease of bone	0.00153	0.00236	CcSEcCtD
Regorafenib—Dermatitis—Pamidronate—Paget's disease of bone	0.00153	0.00236	CcSEcCtD
Regorafenib—Headache—Pamidronate—Paget's disease of bone	0.00152	0.00235	CcSEcCtD
Regorafenib—Diarrhoea—Zoledronate—Paget's disease of bone	0.00152	0.00234	CcSEcCtD
Regorafenib—Nausea—Risedronate—Paget's disease of bone	0.00152	0.00234	CcSEcCtD
Regorafenib—EPHX2—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	0.00151	0.00481	CbGpPWpGaD
Regorafenib—RAF1—Senescence and Autophagy in Cancer—SQSTM1—Paget's disease of bone	0.00151	0.00479	CbGpPWpGaD
Regorafenib—RAF1—Signaling by Interleukins—SQSTM1—Paget's disease of bone	0.00147	0.00468	CbGpPWpGaD
Regorafenib—RAF1—BDNF signaling pathway—ALPL—Paget's disease of bone	0.00147	0.00468	CbGpPWpGaD
Regorafenib—RAF1—TGF-beta Signaling Pathway—PML—Paget's disease of bone	0.00145	0.00461	CbGpPWpGaD
Regorafenib—Nausea—Pamidronate—Paget's disease of bone	0.00144	0.00222	CcSEcCtD
Regorafenib—ABL1—Integrated Breast Cancer Pathway—PML—Paget's disease of bone	0.00143	0.00453	CbGpPWpGaD
Regorafenib—Vomiting—Zoledronate—Paget's disease of bone	0.00141	0.00218	CcSEcCtD
Regorafenib—Rash—Zoledronate—Paget's disease of bone	0.0014	0.00216	CcSEcCtD
Regorafenib—Dermatitis—Zoledronate—Paget's disease of bone	0.0014	0.00216	CcSEcCtD
Regorafenib—Headache—Zoledronate—Paget's disease of bone	0.00139	0.00214	CcSEcCtD
Regorafenib—MAPK11—Metabolism of RNA—NUP205—Paget's disease of bone	0.00137	0.00435	CbGpPWpGaD
Regorafenib—TEK—Hemostasis—INPP5D—Paget's disease of bone	0.00135	0.0043	CbGpPWpGaD
Regorafenib—FGFR1—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.00135	0.00429	CbGpPWpGaD
Regorafenib—PDGFRA—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.00134	0.00428	CbGpPWpGaD
Regorafenib—Nausea—Zoledronate—Paget's disease of bone	0.00132	0.00203	CcSEcCtD
Regorafenib—ABL1—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.0013	0.00413	CbGpPWpGaD
Regorafenib—NTRK1—Signaling by NGF—SQSTM1—Paget's disease of bone	0.00121	0.00386	CbGpPWpGaD
Regorafenib—UGT1A1—NRF2 pathway—SQSTM1—Paget's disease of bone	0.00119	0.00378	CbGpPWpGaD
Regorafenib—UGT1A9—NRF2 pathway—SQSTM1—Paget's disease of bone	0.00119	0.00378	CbGpPWpGaD
Regorafenib—RAF1—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.00119	0.00378	CbGpPWpGaD
Regorafenib—ABL1—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.00118	0.00375	CbGpPWpGaD
Regorafenib—RAF1—BDNF signaling pathway—SQSTM1—Paget's disease of bone	0.00117	0.00372	CbGpPWpGaD
Regorafenib—RAF1—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.00108	0.00343	CbGpPWpGaD
Regorafenib—MAPK11—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000987	0.00314	CbGpPWpGaD
Regorafenib—BRAF—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000977	0.00311	CbGpPWpGaD
Regorafenib—FGFR2—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000906	0.00288	CbGpPWpGaD
Regorafenib—RAF1—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.0009	0.00286	CbGpPWpGaD
Regorafenib—KIT—Signaling by NGF—SQSTM1—Paget's disease of bone	0.00089	0.00283	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—VCP—Paget's disease of bone	0.00085	0.0027	CbGpPWpGaD
Regorafenib—FGFR1—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000844	0.00268	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000842	0.00268	CbGpPWpGaD
Regorafenib—RAF1—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.000795	0.00253	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—NUP205—Paget's disease of bone	0.00079	0.00251	CbGpPWpGaD
Regorafenib—RAF1—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.000767	0.00244	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000759	0.00241	CbGpPWpGaD
Regorafenib—RAF1—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000688	0.00219	CbGpPWpGaD
Regorafenib—RAF1—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000676	0.00215	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—INPP5D—Paget's disease of bone	0.000673	0.00214	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—VCP—Paget's disease of bone	0.000634	0.00202	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000553	0.00176	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000544	0.00173	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—INPP5D—Paget's disease of bone	0.000523	0.00166	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000516	0.00164	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000515	0.00164	CbGpPWpGaD
Regorafenib—BRAF—Disease—VCP—Paget's disease of bone	0.000513	0.00163	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.000509	0.00162	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000496	0.00158	CbGpPWpGaD
Regorafenib—RAF1—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000485	0.00154	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—CALCA—Paget's disease of bone	0.000482	0.00153	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—INPP5D—Paget's disease of bone	0.000478	0.00152	CbGpPWpGaD
Regorafenib—FGFR2—Disease—VCP—Paget's disease of bone	0.000476	0.00151	CbGpPWpGaD
Regorafenib—KIT—Disease—VCP—Paget's disease of bone	0.000467	0.00148	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000464	0.00147	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	0.000447	0.00142	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—VCP—Paget's disease of bone	0.000446	0.00142	CbGpPWpGaD
Regorafenib—FGFR1—Disease—VCP—Paget's disease of bone	0.000443	0.00141	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—VCP—Paget's disease of bone	0.000442	0.00141	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—NUP205—Paget's disease of bone	0.000429	0.00136	CbGpPWpGaD
Regorafenib—MAPK11—Gene Expression—NUP205—Paget's disease of bone	0.000426	0.00136	CbGpPWpGaD
Regorafenib—ABCG2—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000423	0.00135	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—VCP—Paget's disease of bone	0.000422	0.00134	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000413	0.00131	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—VCP—Paget's disease of bone	0.000398	0.00127	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—NUP205—Paget's disease of bone	0.000394	0.00125	CbGpPWpGaD
Regorafenib—BRAF—Disease—NUP205—Paget's disease of bone	0.000392	0.00125	CbGpPWpGaD
Regorafenib—KIT—Immune System—NUP205—Paget's disease of bone	0.000387	0.00123	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—PML—Paget's disease of bone	0.000379	0.0012	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—SQSTM1—Paget's disease of bone	0.00037	0.00118	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—NUP205—Paget's disease of bone	0.000367	0.00117	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—NUP205—Paget's disease of bone	0.000366	0.00116	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—INPP5D—Paget's disease of bone	0.000366	0.00116	CbGpPWpGaD
Regorafenib—FGFR2—Disease—NUP205—Paget's disease of bone	0.000363	0.00116	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—VCP—Paget's disease of bone	0.000363	0.00115	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—CALCA—Paget's disease of bone	0.00036	0.00114	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—VCP—Paget's disease of bone	0.000359	0.00114	CbGpPWpGaD
Regorafenib—KIT—Disease—NUP205—Paget's disease of bone	0.000357	0.00113	CbGpPWpGaD
Regorafenib—RAF1—Disease—VCP—Paget's disease of bone	0.000355	0.00113	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—PML—Paget's disease of bone	0.000348	0.00111	CbGpPWpGaD
Regorafenib—KIT—Immune System—PML—Paget's disease of bone	0.000342	0.00109	CbGpPWpGaD
Regorafenib—FGFR1—Disease—NUP205—Paget's disease of bone	0.000339	0.00108	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—NUP205—Paget's disease of bone	0.000338	0.00107	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—INPP5D—Paget's disease of bone	0.000336	0.00107	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—VCP—Paget's disease of bone	0.000333	0.00106	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—NUP205—Paget's disease of bone	0.00033	0.00105	CbGpPWpGaD
Regorafenib—KIT—Immune System—INPP5D—Paget's disease of bone	0.00033	0.00105	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—SQSTM1—Paget's disease of bone	0.000328	0.00104	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—VCP—Paget's disease of bone	0.000327	0.00104	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—PML—Paget's disease of bone	0.000324	0.00103	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—PML—Paget's disease of bone	0.000323	0.00103	CbGpPWpGaD
Regorafenib—ABL1—Immune System—NUP205—Paget's disease of bone	0.000321	0.00102	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—INPP5D—Paget's disease of bone	0.000313	0.000995	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—INPP5D—Paget's disease of bone	0.000312	0.000992	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—VCP—Paget's disease of bone	0.00031	0.000987	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—VCP—Paget's disease of bone	0.00031	0.000984	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—NUP205—Paget's disease of bone	0.000304	0.000968	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—SQSTM1—Paget's disease of bone	0.000301	0.000957	CbGpPWpGaD
Regorafenib—KIT—Immune System—SQSTM1—Paget's disease of bone	0.000296	0.000939	CbGpPWpGaD
Regorafenib—RAF1—Immune System—NUP205—Paget's disease of bone	0.000294	0.000934	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—PML—Paget's disease of bone	0.000291	0.000926	CbGpPWpGaD
Regorafenib—BRAF—Disease—CALCA—Paget's disease of bone	0.000291	0.000925	CbGpPWpGaD
Regorafenib—ABL1—Immune System—PML—Paget's disease of bone	0.000284	0.000903	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—INPP5D—Paget's disease of bone	0.000281	0.000894	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—SQSTM1—Paget's disease of bone	0.00028	0.000892	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—SQSTM1—Paget's disease of bone	0.00028	0.000889	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—VCP—Paget's disease of bone	0.000279	0.000887	CbGpPWpGaD
Regorafenib—ABL1—Immune System—INPP5D—Paget's disease of bone	0.000274	0.000871	CbGpPWpGaD
Regorafenib—RAF1—Disease—NUP205—Paget's disease of bone	0.000271	0.000862	CbGpPWpGaD
Regorafenib—FGFR2—Disease—CALCA—Paget's disease of bone	0.00027	0.000858	CbGpPWpGaD
Regorafenib—KIT—Disease—CALCA—Paget's disease of bone	0.000265	0.000842	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000261	0.000829	CbGpPWpGaD
Regorafenib—RAF1—Immune System—PML—Paget's disease of bone	0.00026	0.000826	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—CALCA—Paget's disease of bone	0.000253	0.000805	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—SQSTM1—Paget's disease of bone	0.000252	0.000801	CbGpPWpGaD
Regorafenib—FGFR1—Disease—CALCA—Paget's disease of bone	0.000251	0.000799	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—CALCA—Paget's disease of bone	0.000251	0.000797	CbGpPWpGaD
Regorafenib—RAF1—Immune System—INPP5D—Paget's disease of bone	0.000251	0.000797	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—VCP—Paget's disease of bone	0.000249	0.00079	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000246	0.000783	CbGpPWpGaD
Regorafenib—ABL1—Immune System—SQSTM1—Paget's disease of bone	0.000246	0.000781	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—CALCA—Paget's disease of bone	0.000239	0.000761	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—CALCA—Paget's disease of bone	0.000239	0.000759	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	0.000236	0.000749	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—NUP205—Paget's disease of bone	0.000234	0.000743	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—NUP205—Paget's disease of bone	0.000234	0.000743	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000229	0.000727	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—CALCA—Paget's disease of bone	0.000226	0.000718	CbGpPWpGaD
Regorafenib—RAF1—Immune System—SQSTM1—Paget's disease of bone	0.000225	0.000714	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000212	0.000674	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	0.00021	0.000668	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—SQSTM1—Paget's disease of bone	0.00021	0.000667	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—CALCA—Paget's disease of bone	0.000206	0.000654	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—CALCA—Paget's disease of bone	0.000204	0.000648	CbGpPWpGaD
Regorafenib—RAF1—Disease—CALCA—Paget's disease of bone	0.000201	0.00064	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—INPP5D—Paget's disease of bone	0.000199	0.000633	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—INPP5D—Paget's disease of bone	0.000199	0.000633	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—NUP205—Paget's disease of bone	0.000198	0.00063	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000195	0.000618	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	0.000192	0.000609	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000191	0.000607	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—CALCA—Paget's disease of bone	0.000189	0.000601	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—CALCA—Paget's disease of bone	0.000186	0.00059	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000181	0.000576	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000181	0.000575	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CALCA—Paget's disease of bone	0.000176	0.00056	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CALCA—Paget's disease of bone	0.000176	0.000558	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—INPP5D—Paget's disease of bone	0.000169	0.000537	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000163	0.000518	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CALCA—Paget's disease of bone	0.000158	0.000503	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—NUP205—Paget's disease of bone	0.000145	0.000462	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000145	0.000462	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CALCA—Paget's disease of bone	0.000141	0.000448	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—INPP5D—Paget's disease of bone	0.000124	0.000394	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—NUP205—Paget's disease of bone	0.000123	0.000391	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—NUP205—Paget's disease of bone	0.00011	0.000349	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—NUP205—Paget's disease of bone	0.000107	0.000341	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—INPP5D—Paget's disease of bone	0.000105	0.000333	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—NUP205—Paget's disease of bone	0.0001	0.000318	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—INPP5D—Paget's disease of bone	9.36e-05	0.000298	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—INPP5D—Paget's disease of bone	9.14e-05	0.00029	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—INPP5D—Paget's disease of bone	8.54e-05	0.000271	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—NUP205—Paget's disease of bone	6.6e-05	0.00021	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—INPP5D—Paget's disease of bone	5.63e-05	0.000179	CbGpPWpGaD
